BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 256558)

  • 1. Clinical pharmacology of antiarrhythmic agents.
    Graboys TB
    Heart Lung; 1979; 8(4):706-10. PubMed ID: 256558
    [No Abstract]   [Full Text] [Related]  

  • 2. Rational basis of antiarrhythmic therapy: clinical pharmacology of commonly used antiarrhythmic drugs.
    Singh BN
    Angiology; 1978 Mar; 29(3):206-42. PubMed ID: 347988
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electrophysiologic study of antiarrhythmic agents in man].
    Puech P
    Arch Inst Cardiol Mex; 1977; 47(2):233-47. PubMed ID: 901058
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiarrhythmic drugs.
    Awalt CH
    Clin Anesth; 1974; 10(1):167-83. PubMed ID: 4598995
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacology of cardio-active agents.
    Hayes AH
    Cardiovasc Clin; 1972; 4(3):103-18. PubMed ID: 4130206
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacology of antiarrhythmic drugs.
    Rusy BF
    Med Clin North Am; 1974 Sep; 58(5):987-94. PubMed ID: 4608525
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiarrhythmic agents and their use in therapy.
    Dreifus LS; Morganroth J
    Pharmacol Ther; 1980; 9(1):75-106. PubMed ID: 6994141
    [No Abstract]   [Full Text] [Related]  

  • 8. Arrhythmias and antiarrhythmic drugs.
    Bigger JT
    Adv Intern Med; 1972; 18():251-81. PubMed ID: 4576083
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical pharmacology of anti-arrhythmia agents].
    Rahn KH
    Verh Dtsch Ges Inn Med; 1975; 81():111-9. PubMed ID: 1229410
    [No Abstract]   [Full Text] [Related]  

  • 10. Observations on the effects of selected antiarrhythmic drugs on mammalian cardiac purkinje fibers with two levels of steady-state potential: influences of lidocaine, phenytoin, propranolol, disopyramide and procainamide on repolarization, action potential shape and conduction.
    Arnsdorf MF; Mehlman DJ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):983-91. PubMed ID: 731444
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electrophysiological principles of the action of antiarrhythmia agents].
    Sanna GP; Lomanto B; Rossi A
    Minerva Cardioangiol; 1974 Nov; 22(11):731-58. PubMed ID: 4453368
    [No Abstract]   [Full Text] [Related]  

  • 12. Ventricular arrhythmias: current concepts.
    Nestico PF; Morganroth J
    Compr Ther; 1984 Sep; 10(9):32-6. PubMed ID: 6435947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Actions of anti-arrhythmic agents on physiology of myocardial cell membrane].
    Mashiba H; Kanaya S
    Nihon Rinsho; 1974 Sep; 32(9):2829-34. PubMed ID: 4613891
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology.
    Mason DT; DeMaria AN; Amsterdam EA; Zelis R; Massumi RA
    Drugs; 1973; 5(4):261-91. PubMed ID: 4146767
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiarrhythmic agents.
    Palmer RF
    Int Anesthesiol Clin; 1968; 6(1):115-21. PubMed ID: 5704449
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative mechanisms of action of antiarrhythmic drugs.
    Singh BN; Hauswirth O
    Am Heart J; 1974 Mar; 87(3):367-82. PubMed ID: 4149610
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mode of action of antiarrhythmic drugs (author's transl)].
    Sano T
    Kokyu To Junkan; 1974 Apr; 22(4):321-6. PubMed ID: 4603686
    [No Abstract]   [Full Text] [Related]  

  • 18. Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs.
    Hasannejad H; Takeda M; Narikawa S; Huang XL; Enomoto A; Taki K; Niwa T; Jung SH; Onozato ML; Tojo A; Endou H
    Eur J Pharmacol; 2004 Sep; 499(1-2):45-51. PubMed ID: 15363950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electropharmacology of antiarrhythmic drugs.
    Rosen MR; Wit AL
    Am Heart J; 1983 Oct; 106(4 Pt 2):829-39. PubMed ID: 6412533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic drugs: electrophysiological and pharmacokinetic considerations.
    Sasyniuk BI; Ogilvie RI
    Annu Rev Pharmacol; 1975; 15():131-55. PubMed ID: 1096787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.